Functionalized lipid-based drug delivery nanosystems for the treatment of human infectious diseases

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.contributorUniversidade Estadual de Campinas (UNICAMP)-
Autor(es): dc.creatorAlmeida Furquim de Camargo, Bruna-
Autor(es): dc.creatorFonseca-Santos, Bruno-
Autor(es): dc.creatorGonçalves Carvalho, Suzana-
Autor(es): dc.creatorCorrêa Carvalho, Gabriela-
Autor(es): dc.creatorDelello Di Filippo, Leonardo-
Autor(es): dc.creatorSousa Araújo, Victor Hugo-
Autor(es): dc.creatorLobato Duarte, Jonatas-
Autor(es): dc.creatorPolli Silvestre, Amanda Letícia-
Autor(es): dc.creatorBauab, Taís Maria-
Autor(es): dc.creatorChorilli, Marlus-
Data de aceite: dc.date.accessioned2025-08-21T19:36:44Z-
Data de disponibilização: dc.date.available2025-08-21T19:36:44Z-
Data de envio: dc.date.issued2023-03-02-
Data de envio: dc.date.issued2023-03-02-
Data de envio: dc.date.issued2021-12-31-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1080/1040841X.2022.2047007-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/241902-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/241902-
Descrição: dc.descriptionInfectious diseases are still public health problems. Microorganisms such as fungi, bacteria, viruses, and parasites are the main causing agents related to these diseases. In this context, the search for new effective strategies in prevention and/or treatment is considered essential, since current drugs often have side effects or end up, causing microbial resistance, making it a serious health problem. As an alternative to these limitations, nanotechnology has been widely used. The use of lipid-based drug delivery nanosystems (DDNs) has some advantages, such as biocompatibility, low toxicity, controlled release, the ability to carry both hydrophilic and lipophilic drugs, in addition to be easel scalable. Besides, as an improvement, studies involving the conjugation of signalling molecules on the surfaces of these nanocarriers can allow the target of certain tissues or cells. Thus, this review summarizes the performance of functionalized lipid-based DDNs for the treatment of infectious diseases caused by viruses, including SARS-CoV-2, bacteria, fungi, and parasites.-
Descrição: dc.descriptionSchool of Pharmaceutical Sciences São Paulo State University (UNESP)-
Descrição: dc.descriptionFaculty of Pharmaceutical Sciences Campinas State University (UNICAMP)-
Descrição: dc.descriptionSchool of Pharmaceutical Sciences São Paulo State University (UNESP)-
Idioma: dc.languageen-
Relação: dc.relationCritical Reviews in Microbiology-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectdrug delivery nanosystem-
Palavras-chave: dc.subjectfunctionalization-
Palavras-chave: dc.subjectinfectious diseases-
Palavras-chave: dc.subjectnanotechnology-
Palavras-chave: dc.subjectTargeting-
Título: dc.titleFunctionalized lipid-based drug delivery nanosystems for the treatment of human infectious diseases-
Tipo de arquivo: dc.typevídeo-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.